_id
691055e9ccc777a4e85d55f3
Ticker
CSPCY
Name
CSPC Pharmaceutical Group Limited
Exchange
PINK
Address
No.896 Zhongshandong Street, Shijiazhuang, China, 050035
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
USD
Website
https://www.cspc.com.hk
Description
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson's disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer. It also offers Shuluoke, Nuomoling, Weihong, and Xinweihong for various infections; Xuanning for hypertension; Encun to prevent atherosclerotic thrombosis events; Qixiao to treat upper respiratory tract infection; Linmeixin and Shuanglexin for diabetes; Gubang and Gubangjia to treat osteoporosis in postmenopausal women; and Gaoshunsong for arthritis, osteoarthritis, ankylosing spondylitis, frozen shoulder, bursuitis, tenosynovitis, acute gout, dysmenorrhea, toothache and postoperative pain, low back pain, sprain, strain, and other soft tissue injuries. In addition, the company provides Debixin for various ulcer; Qimaite for acute and chronic pains; antibiotics, vitamin C, and caffeine APIs; functional food products; and healthcare services. It has a strategic collaboration with AstraZeneca PLC to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the People's Republic of China.
Last Close
4.31
Volume
-
Current Price
4.53
Change
-2.561247216035639
Last Updated
2026-01-02T12:05:33.651Z
Image
-
Ipo Date
-
Market Cap
12453486592
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
1829618291
Cost Of Revenue
628998450
Gross Profit
1200619841
Operating Expenses
6720889006
Operating Income
354109295
Interest Expense
2984529
Pretax Income
429741716
Net Income
351197822
Eps
0.12287240948883868
Dividends Per Share
-
Shares Outstanding
2855612933
Income Tax Expense
595677173
EBITDA
3480613903
Operating Margin
19.354271693821843
Total Other Income Expense Net
75632421
Cash
7570931000
Short Term Investments
2132500000
Receivables
9438969000
Inventories
2870785000
Total Current Assets
22610088000
Property Plant Equipment
13630517000
Total Assets
46002354000
Payables
2287643000
Short Term Debt
336250000
Long Term Debt
-
Total Liabilities
11138478000
Equity
33249629000
Bs_currency_symbol
CNY
Depreciation
757716898
Change In Working Capital
-
Cash From Operations
455836771
Capital Expenditures
165850331
Cash From Investing
-317642960
Cash From Financing
-21481248
Net Change In Cash
239074036
Cf_currency_symbol
CNY
PE
22.6842
PB
0.3894115578703149
ROE
1.0562458366076806
ROA
0.7634344581583803
FCF
289986440
Fcf Percent
0.1584955951886032
Piotroski FScore
4
Health Score
66
Deep Value Investing Score
9
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
9.3
Garp Investing Score
4
Growth Investing Score
3
Momentum Investing Score
8
Net Net Investing Score
6
Quality Investing Score
8
Value Investing Score
7
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
1829618291
Quarters > 0 > income Statement > cost Of Revenue
628998450
Quarters > 0 > income Statement > gross Profit
1200619841
Quarters > 0 > income Statement > operating Expenses
6720889006
Quarters > 0 > income Statement > operating Income
354109295
Quarters > 0 > income Statement > interest Expense
2984529
Quarters > 0 > income Statement > pretax Income
429741716
Quarters > 0 > income Statement > net Income
351197822
Quarters > 0 > income Statement > eps
0.12287240948883868
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
2858231750
Quarters > 0 > income Statement > income Tax Expense
595677173
Quarters > 0 > income Statement > EBITDA
3480613903
Quarters > 0 > income Statement > operating Margin
19.354271693821843
Quarters > 0 > income Statement > total Other Income Expense Net
75632421
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
7570931000
Quarters > 0 > balance Sheet > short Term Investments
2132500000
Quarters > 0 > balance Sheet > receivables
9438969000
Quarters > 0 > balance Sheet > inventories
2870785000
Quarters > 0 > balance Sheet > total Current Assets
22610088000
Quarters > 0 > balance Sheet > property Plant Equipment
13630517000
Quarters > 0 > balance Sheet > total Assets
46002354000
Quarters > 0 > balance Sheet > payables
2287643000
Quarters > 0 > balance Sheet > short Term Debt
336250000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
11138478000
Quarters > 0 > balance Sheet > equity
33249629000
Quarters > 0 > balance Sheet > currency_symbol
CNY
Quarters > 0 > cash Flow > net Income
2791849193
Quarters > 0 > cash Flow > depreciation
757716898
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
455836771
Quarters > 0 > cash Flow > capital Expenditures
165850331
Quarters > 0 > cash Flow > cash From Investing
-317642960
Quarters > 0 > cash Flow > cash From Financing
-21481248
Quarters > 0 > cash Flow > net Change In Cash
239074036
Quarters > 0 > cash Flow > currency_symbol
CNY
Quarters > 0 > ratios > PE
0.12287240948883868
Quarters > 0 > ratios > PB
0.3894115578703149
Quarters > 0 > ratios > ROE
1.0562458366076806
Quarters > 0 > ratios > ROA
0.7634344581583803
Quarters > 0 > ratios > FCF
289986440
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.1584955951886032
Quarters > 0 > health Score
66
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
14591337000
Quarters > 1 > income Statement > cost Of Revenue
4641094000
Quarters > 1 > income Statement > gross Profit
9950243000
Quarters > 1 > income Statement > operating Expenses
7524009000
Quarters > 1 > income Statement > operating Income
2009410000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
2136831000
Quarters > 1 > income Statement > net Income
1586394000
Quarters > 1 > income Statement > eps
0.5405991441673881
Quarters > 1 > income Statement > dividends Per Share
1848130000
Quarters > 1 > income Statement > shares Outstanding
2934510750
Quarters > 1 > income Statement > income Tax Expense
570034000
Quarters > 1 > income Statement > EBITDA
2497898000
Quarters > 1 > income Statement > operating Margin
13.771253449906611
Quarters > 1 > income Statement > total Other Income Expense Net
127421000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
6777199000
Quarters > 1 > balance Sheet > short Term Investments
1473112000
Quarters > 1 > balance Sheet > receivables
9938393000
Quarters > 1 > balance Sheet > inventories
3130014000
Quarters > 1 > balance Sheet > total Current Assets
21888144000
Quarters > 1 > balance Sheet > property Plant Equipment
13079000000
Quarters > 1 > balance Sheet > total Assets
44388991000
Quarters > 1 > balance Sheet > payables
2613000000
Quarters > 1 > balance Sheet > short Term Debt
451195000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
10522701000
Quarters > 1 > balance Sheet > equity
32264695000
Quarters > 1 > balance Sheet > currency_symbol
CNY
Quarters > 1 > cash Flow > net Income
1391443000
Quarters > 1 > cash Flow > depreciation
753276000
Quarters > 1 > cash Flow > change In Working Capital
-205916000
Quarters > 1 > cash Flow > cash From Operations
3308449000
Quarters > 1 > cash Flow > capital Expenditures
648891000
Quarters > 1 > cash Flow > cash From Investing
-2180673000
Quarters > 1 > cash Flow > cash From Financing
-3154584000
Quarters > 1 > cash Flow > net Change In Cash
-7491833000
Quarters > 1 > cash Flow > currency_symbol
CNY
Quarters > 1 > ratios > PE
0.5405991441673881
Quarters > 1 > ratios > PB
0.4120086583028292
Quarters > 1 > ratios > ROE
4.916810774129432
Quarters > 1 > ratios > ROA
3.5738455960848494
Quarters > 1 > ratios > FCF
2659558000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.1822696576742762
Quarters > 1 > health Score
74
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
16276552000
Quarters > 2 > income Statement > cost Of Revenue
4627537000
Quarters > 2 > income Statement > gross Profit
11649015000
Quarters > 2 > income Statement > operating Expenses
8365292000
Quarters > 2 > income Statement > operating Income
3700547000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
3799326000
Quarters > 2 > income Statement > net Income
3018940000
Quarters > 2 > income Statement > eps
1.020024675019052
Quarters > 2 > income Statement > dividends Per Share
1531128000
Quarters > 2 > income Statement > shares Outstanding
2959673500
Quarters > 2 > income Statement > income Tax Expense
749308000
Quarters > 2 > income Statement > EBITDA
4524819000
Quarters > 2 > income Statement > operating Margin
22.735447900759326
Quarters > 2 > income Statement > total Other Income Expense Net
98779000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
8370714000
Quarters > 2 > balance Sheet > short Term Investments
2442314000
Quarters > 2 > balance Sheet > receivables
11912707000
Quarters > 2 > balance Sheet > inventories
3457142000
Quarters > 2 > balance Sheet > total Current Assets
26453688000
Quarters > 2 > balance Sheet > property Plant Equipment
12234731000
Quarters > 2 > balance Sheet > total Assets
47873610000
Quarters > 2 > balance Sheet > payables
3228933000
Quarters > 2 > balance Sheet > short Term Debt
322554000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
11424007000
Quarters > 2 > balance Sheet > equity
34834421000
Quarters > 2 > balance Sheet > currency_symbol
CNY
Quarters > 2 > cash Flow > net Income
3018940000
Quarters > 2 > cash Flow > depreciation
631231000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
1424748000
Quarters > 2 > cash Flow > capital Expenditures
648891000
Quarters > 2 > cash Flow > cash From Investing
-2132395000
Quarters > 2 > cash Flow > cash From Financing
-2287608000
Quarters > 2 > cash Flow > net Change In Cash
8054003000
Quarters > 2 > cash Flow > currency_symbol
CNY
Quarters > 2 > ratios > PE
1.020024675019052
Quarters > 2 > ratios > PB
0.384887148117088
Quarters > 2 > ratios > ROE
8.666542785367382
Quarters > 2 > ratios > ROA
6.306062985431849
Quarters > 2 > ratios > FCF
775857000
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.0476671594819345
Quarters > 2 > health Score
65
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
8982734000
Quarters > 3 > income Statement > cost Of Revenue
2487305000
Quarters > 3 > income Statement > gross Profit
6495429000
Quarters > 3 > income Statement > operating Expenses
4461649000
Quarters > 3 > income Statement > operating Income
2033780000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
2058237000
Quarters > 3 > income Statement > net Income
1612850000
Quarters > 3 > income Statement > eps
0.5443999811653167
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
2962619500
Quarters > 3 > income Statement > income Tax Expense
428350000
Quarters > 3 > income Statement > EBITDA
2263398500
Quarters > 3 > income Statement > operating Margin
22.640991039031103
Quarters > 3 > income Statement > total Other Income Expense Net
24457000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
-
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
-
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
1739895090
Quarters > 3 > cash Flow > depreciation
229618500
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
CNY
Quarters > 3 > ratios > PE
0.5443999811653167
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
54
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
30867889000
Annuals > 0 > income Statement > cost Of Revenue
9268631000
Annuals > 0 > income Statement > gross Profit
21599258000
Annuals > 0 > income Statement > operating Expenses
15889301000
Annuals > 0 > income Statement > operating Income
5709957000
Annuals > 0 > income Statement > interest Expense
43673000
Annuals > 0 > income Statement > pretax Income
5936157000
Annuals > 0 > income Statement > net Income
4605334000
Annuals > 0 > income Statement > eps
1.5693702945201342
Annuals > 0 > income Statement > dividends Per Share
3441006887
Annuals > 0 > income Statement > shares Outstanding
2934510750
Annuals > 0 > income Statement > income Tax Expense
1319342000
Annuals > 0 > income Statement > EBITDA
6864511000
Annuals > 0 > income Statement > operating Margin
18.498048246836703
Annuals > 0 > income Statement > total Other Income Expense Net
226200000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
6777199000
Annuals > 0 > balance Sheet > short Term Investments
1473112000
Annuals > 0 > balance Sheet > receivables
9938393000
Annuals > 0 > balance Sheet > inventories
3130014000
Annuals > 0 > balance Sheet > total Current Assets
21888144000
Annuals > 0 > balance Sheet > property Plant Equipment
13079000000
Annuals > 0 > balance Sheet > total Assets
44388991000
Annuals > 0 > balance Sheet > payables
2613000000
Annuals > 0 > balance Sheet > short Term Debt
451195000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
10522701000
Annuals > 0 > balance Sheet > equity
32264695000
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
4605334000
Annuals > 0 > cash Flow > depreciation
1339450000
Annuals > 0 > cash Flow > change In Working Capital
-205915716
Annuals > 0 > cash Flow > cash From Operations
4534664000
Annuals > 0 > cash Flow > capital Expenditures
2678876000
Annuals > 0 > cash Flow > cash From Investing
-3858200000
Annuals > 0 > cash Flow > cash From Financing
-5253332000
Annuals > 0 > cash Flow > net Change In Cash
-4573469000
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
1.5693702945201342
Annuals > 0 > ratios > PB
0.39199940778922593
Annuals > 0 > ratios > ROE
14.273601532572988
Annuals > 0 > ratios > ROA
10.374946346493887
Annuals > 0 > ratios > FCF
1855788000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.060120340590832114
Annuals > 0 > health Score
74
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
34599374000
Annuals > 1 > income Statement > cost Of Revenue
10202020000
Annuals > 1 > income Statement > gross Profit
24397354000
Annuals > 1 > income Statement > operating Expenses
16717231000
Annuals > 1 > income Statement > operating Income
7680123000
Annuals > 1 > income Statement > interest Expense
25896000
Annuals > 1 > income Statement > pretax Income
7389372000
Annuals > 1 > income Statement > net Income
5873325000
Annuals > 1 > income Statement > eps
1.9787112490483685
Annuals > 1 > income Statement > dividends Per Share
2999247034
Annuals > 1 > income Statement > shares Outstanding
2968257750
Annuals > 1 > income Statement > income Tax Expense
1316679000
Annuals > 1 > income Statement > EBITDA
8532758000
Annuals > 1 > income Statement > operating Margin
22.197288887365417
Annuals > 1 > income Statement > total Other Income Expense Net
-290751000
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
12015223000
Annuals > 1 > balance Sheet > short Term Investments
1077054000
Annuals > 1 > balance Sheet > receivables
10835378000
Annuals > 1 > balance Sheet > inventories
3138664000
Annuals > 1 > balance Sheet > total Current Assets
26744945000
Annuals > 1 > balance Sheet > property Plant Equipment
11642892000
Annuals > 1 > balance Sheet > total Assets
46282170000
Annuals > 1 > balance Sheet > payables
2841739000
Annuals > 1 > balance Sheet > short Term Debt
599843000
Annuals > 1 > balance Sheet > long Term Debt
0
Annuals > 1 > balance Sheet > total Liabilities
12392097313
Annuals > 1 > balance Sheet > equity
33203208000
Annuals > 1 > balance Sheet > currency_symbol
CNY
Annuals > 1 > cash Flow > net Income
7389372000
Annuals > 1 > cash Flow > depreciation
1117490000
Annuals > 1 > cash Flow > change In Working Capital
-2745539000
Annuals > 1 > cash Flow > cash From Operations
4178815000
Annuals > 1 > cash Flow > capital Expenditures
1893067000
Annuals > 1 > cash Flow > cash From Investing
607267000
Annuals > 1 > cash Flow > cash From Financing
-2300981000
Annuals > 1 > cash Flow > net Change In Cash
2489993000
Annuals > 1 > cash Flow > currency_symbol
CNY
Annuals > 1 > ratios > PE
1.9787112490483685
Annuals > 1 > ratios > PB
0.3852998451986928
Annuals > 1 > ratios > ROE
17.68902872276679
Annuals > 1 > ratios > ROA
12.690254151868851
Annuals > 1 > ratios > FCF
2285748000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.066063276173725
Annuals > 1 > health Score
77
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
35012349000
Annuals > 2 > income Statement > cost Of Revenue
8863817000
Annuals > 2 > income Statement > gross Profit
22726458000
Annuals > 2 > income Statement > operating Expenses
17605130000
Annuals > 2 > income Statement > operating Income
7583213000
Annuals > 2 > income Statement > interest Expense
24891000
Annuals > 2 > income Statement > pretax Income
8581103000
Annuals > 2 > income Statement > net Income
6893834000
Annuals > 2 > income Statement > eps
2.3136537975385036
Annuals > 2 > income Statement > dividends Per Share
2096961000
Annuals > 2 > income Statement > shares Outstanding
2979630750
Annuals > 2 > income Statement > income Tax Expense
1350211000
Annuals > 2 > income Statement > EBITDA
8655091000
Annuals > 2 > income Statement > operating Margin
21.658681055646966
Annuals > 2 > income Statement > total Other Income Expense Net
997891000
Annuals > 2 > income Statement > currency_symbol
CNY
Annuals > 2 > balance Sheet > cash
11654605553
Annuals > 2 > balance Sheet > short Term Investments
4830335018
Annuals > 2 > balance Sheet > receivables
7623543000
Annuals > 2 > balance Sheet > inventories
2554861000
Annuals > 2 > balance Sheet > total Current Assets
23957160000
Annuals > 2 > balance Sheet > property Plant Equipment
11773489000
Annuals > 2 > balance Sheet > total Assets
41769774000
Annuals > 2 > balance Sheet > payables
2010065000
Annuals > 2 > balance Sheet > short Term Debt
334489593
Annuals > 2 > balance Sheet > long Term Debt
28950000
Annuals > 2 > balance Sheet > total Liabilities
11462088531
Annuals > 2 > balance Sheet > equity
29770965000
Annuals > 2 > balance Sheet > currency_symbol
CNY
Annuals > 2 > cash Flow > net Income
7582261000
Annuals > 2 > cash Flow > depreciation
1047939000
Annuals > 2 > cash Flow > change In Working Capital
798120000
Annuals > 2 > cash Flow > cash From Operations
7627064000
Annuals > 2 > cash Flow > capital Expenditures
2722692000
Annuals > 2 > cash Flow > cash From Investing
-6795984000
Annuals > 2 > cash Flow > cash From Financing
-1904073000
Annuals > 2 > cash Flow > net Change In Cash
-1058857000
Annuals > 2 > cash Flow > currency_symbol
CNY
Annuals > 2 > ratios > PE
2.3136537975385036
Annuals > 2 > ratios > PB
0.4313668882584088
Annuals > 2 > ratios > ROE
23.15623292694745
Annuals > 2 > ratios > ROA
16.504360306091197
Annuals > 2 > ratios > FCF
4904372000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.14007549165010322
Annuals > 2 > health Score
87
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
34188155000
Annuals > 3 > income Statement > cost Of Revenue
8113210000
Annuals > 3 > income Statement > gross Profit
25472247000
Annuals > 3 > income Statement > operating Expenses
18266317000
Annuals > 3 > income Statement > operating Income
7663035000
Annuals > 3 > income Statement > interest Expense
7664000
Annuals > 3 > income Statement > pretax Income
8400282000
Annuals > 3 > income Statement > net Income
6876658000
Annuals > 3 > income Statement > eps
2.3010709781184104
Annuals > 3 > income Statement > dividends Per Share
1690763000
Annuals > 3 > income Statement > shares Outstanding
2988459750
Annuals > 3 > income Statement > income Tax Expense
1421872000
Annuals > 3 > income Statement > EBITDA
9275387000
Annuals > 3 > income Statement > operating Margin
22.41429816847385
Annuals > 3 > income Statement > total Other Income Expense Net
737248000
Annuals > 3 > income Statement > currency_symbol
CNY
Annuals > 3 > balance Sheet > cash
9283642000
Annuals > 3 > balance Sheet > short Term Investments
1443413000
Annuals > 3 > balance Sheet > receivables
7129079000
Annuals > 3 > balance Sheet > inventories
2480369000
Annuals > 3 > balance Sheet > total Current Assets
20336503000
Annuals > 3 > balance Sheet > property Plant Equipment
11699213000
Annuals > 3 > balance Sheet > total Assets
42498176000
Annuals > 3 > balance Sheet > payables
1622617000
Annuals > 3 > balance Sheet > short Term Debt
47140000
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
9708397970
Annuals > 3 > balance Sheet > equity
31788603000
Annuals > 3 > balance Sheet > currency_symbol
CNY
Annuals > 3 > cash Flow > net Income
6847096000
Annuals > 3 > cash Flow > depreciation
865471000
Annuals > 3 > cash Flow > change In Working Capital
-1387918000
Annuals > 3 > cash Flow > cash From Operations
4636627000
Annuals > 3 > cash Flow > capital Expenditures
1758448000
Annuals > 3 > cash Flow > cash From Investing
-637326000
Annuals > 3 > cash Flow > cash From Financing
-2196606000
Annuals > 3 > cash Flow > net Change In Cash
1800251000
Annuals > 3 > cash Flow > currency_symbol
CNY
Annuals > 3 > ratios > PE
2.3010709781184104
Annuals > 3 > ratios > PB
0.40518488725345997
Annuals > 3 > ratios > ROE
21.632463685176727
Annuals > 3 > ratios > ROA
16.18106621799486
Annuals > 3 > ratios > FCF
2878179000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.0841864382561738
Annuals > 3 > health Score
81
Valuation > metrics > PE
22.6842
Valuation > metrics > PB
0.3894115578703149
Valuation > final Score
100
Valuation > verdict
30.5% Undervalued
Profitability > metrics > ROE
1.0562458366076806
Profitability > metrics > ROA
1.553279323813335
Profitability > metrics > Net Margin
0.1919514161656356
Profitability > final Score
36
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3349955573940389
Risk > metrics > Interest Coverage
118.64830095469
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
8.617000769467353
Liquidity > metrics > Quick Ratio
7.522906993539752
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
90
Prev Valuations > 2
70
Prev Profitabilities > 0
48
Prev Profitabilities > 1
75
Prev Profitabilities > 2
62
Prev Risks > 0
82
Prev Risks > 1
80
Prev Risks > 2
70
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
50
Updated At
2026-01-20T21:40:00.959Z
Earnings History > 0 > period
2021-06-30
Earnings History > 0 > report Date
2021-09-30
Earnings History > 0 > date
2021-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
CNY
Earnings History > 0 > eps Actual
0.0165
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0.0165
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-03-31
Earnings History > 1 > report Date
2021-06-30
Earnings History > 1 > date
2021-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
CNY
Earnings History > 1 > eps Actual
0.0206
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0.0206
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-12-31
Earnings History > 2 > report Date
2021-03-31
Earnings History > 2 > date
2020-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
CNY
Earnings History > 2 > eps Actual
0.0188
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.0188
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-09-30
Earnings History > 3 > report Date
2020-12-31
Earnings History > 3 > date
2020-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
CNY
Earnings History > 3 > eps Actual
0.021
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0.021
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-06-30
Earnings History > 4 > report Date
2020-09-30
Earnings History > 4 > date
2020-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
CNY
Earnings History > 4 > eps Actual
0.0148
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0.0148
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-03-31
Earnings History > 5 > report Date
2020-06-30
Earnings History > 5 > date
2020-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
CNY
Earnings History > 5 > eps Actual
0.0137
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0.0137
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-12-31
Earnings History > 6 > report Date
2020-03-31
Earnings History > 6 > date
2019-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
CNY
Earnings History > 6 > eps Actual
0.0137
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0.0137
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-09-30
Earnings History > 7 > report Date
2019-12-31
Earnings History > 7 > date
2019-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
CNY
Earnings History > 7 > eps Actual
0.0108
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0.0108
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-06-30
Earnings History > 8 > report Date
2019-09-30
Earnings History > 8 > date
2019-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CNY
Earnings History > 8 > eps Actual
0.0109
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0.0109
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-06-30
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CNY
Earnings History > 9 > eps Actual
0.0113
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0.0113
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-12-31
Earnings History > 10 > report Date
2019-03-31
Earnings History > 10 > date
2018-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CNY
Earnings History > 10 > eps Actual
0.0118
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0.0118
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-12-31
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CNY
Earnings History > 11 > eps Actual
0.0099
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.0099
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-30
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
CNY
Earnings History > 12 > eps Actual
0.0093
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0.0093
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-06-30
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
CNY
Earnings History > 13 > eps Actual
0.0097
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0.0097
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-12-31
Earnings History > 14 > report Date
2018-03-31
Earnings History > 14 > date
2017-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
CNY
Earnings History > 14 > eps Actual
0.0098
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0.0098
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-09-30
Earnings History > 15 > report Date
2017-12-31
Earnings History > 15 > date
2017-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
CNY
Earnings History > 15 > eps Actual
0.0078
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0.0078
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-06-30
Earnings History > 16 > report Date
2017-09-30
Earnings History > 16 > date
2017-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
CNY
Earnings History > 16 > eps Actual
0.008
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0.008
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-03-31
Earnings History > 17 > report Date
2017-06-30
Earnings History > 17 > date
2017-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
CNY
Earnings History > 17 > eps Actual
0.0074
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0.0074
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-12-31
Earnings History > 18 > report Date
2017-03-31
Earnings History > 18 > date
2016-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
CNY
Earnings History > 18 > eps Actual
0.0071
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0.0071
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2016-09-30
Earnings History > 19 > report Date
2016-12-31
Earnings History > 19 > date
2016-09-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
CNY
Earnings History > 19 > eps Actual
0.0059
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0.0059
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2016-06-30
Earnings History > 20 > report Date
2016-09-30
Earnings History > 20 > date
2016-06-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
CNY
Earnings History > 20 > eps Actual
0.006
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
0.006
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2016-03-31
Earnings History > 21 > report Date
2016-06-30
Earnings History > 21 > date
2016-03-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
CNY
Earnings History > 21 > eps Actual
0.0059
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0.0059
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2015-12-31
Earnings History > 22 > report Date
2016-03-31
Earnings History > 22 > date
2015-12-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
CNY
Earnings History > 22 > eps Actual
0.0057
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
0.0057
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2015-09-30
Earnings History > 23 > report Date
2015-12-31
Earnings History > 23 > date
2015-09-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
CNY
Earnings History > 23 > eps Actual
0.0048
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
0.0048
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2015-06-30
Earnings History > 24 > report Date
2015-09-30
Earnings History > 24 > date
2015-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
CNY
Earnings History > 24 > eps Actual
0.0047
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
0.0047
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2015-03-31
Earnings History > 25 > report Date
2015-06-30
Earnings History > 25 > date
2015-03-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
CNY
Earnings History > 25 > eps Actual
0.0047
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
0.0047
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2014-12-31
Earnings History > 26 > report Date
2015-03-31
Earnings History > 26 > date
2014-12-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
CNY
Earnings History > 26 > eps Actual
0.0045
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
0.0045
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2014-09-30
Earnings History > 27 > report Date
2014-12-31
Earnings History > 27 > date
2014-09-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
CNY
Earnings History > 27 > eps Actual
0.0039
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
0.0039
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2014-06-30
Earnings History > 28 > report Date
2014-09-30
Earnings History > 28 > date
2014-06-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
CNY
Earnings History > 28 > eps Actual
0.0036
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
0.0036
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2014-03-31
Earnings History > 29 > report Date
2014-06-30
Earnings History > 29 > date
2014-03-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
CNY
Earnings History > 29 > eps Actual
0.0038
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
0.0038
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2013-12-31
Earnings History > 30 > report Date
2014-03-31
Earnings History > 30 > date
2013-12-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
CNY
Earnings History > 30 > eps Actual
0.0029
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
0.0029
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2013-09-30
Earnings History > 31 > report Date
2013-12-31
Earnings History > 31 > date
2013-09-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
CNY
Earnings History > 31 > eps Actual
0.0024
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
0.0024
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2013-06-30
Earnings History > 32 > report Date
2013-09-30
Earnings History > 32 > date
2013-06-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
CNY
Earnings History > 32 > eps Actual
0.0028
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
0.0028
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2013-03-31
Earnings History > 33 > report Date
2013-06-30
Earnings History > 33 > date
2013-03-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
CNY
Earnings History > 33 > eps Actual
0.0024
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
0.0024
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2012-12-31
Earnings History > 34 > report Date
2013-03-31
Earnings History > 34 > date
2012-12-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
CNY
Earnings History > 34 > eps Actual
0.0025
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
0.0025
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2012-09-30
Earnings History > 35 > report Date
2012-12-31
Earnings History > 35 > date
2012-09-30
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
CNY
Earnings History > 35 > eps Actual
0.0127
Earnings History > 35 > eps Estimate
0
Earnings History > 35 > eps Difference
0.0127
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2012-06-30
Earnings History > 36 > report Date
2012-09-30
Earnings History > 36 > date
2012-06-30
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
CNY
Earnings History > 36 > eps Actual
-0.0032
Earnings History > 36 > eps Estimate
0
Earnings History > 36 > eps Difference
-0.0032
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2012-03-31
Earnings History > 37 > report Date
2012-06-30
Earnings History > 37 > date
2012-03-31
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
CNY
Earnings History > 37 > eps Actual
0.0031
Earnings History > 37 > eps Estimate
0
Earnings History > 37 > eps Difference
0.0031
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2011-12-31
Earnings History > 38 > report Date
2012-03-31
Earnings History > 38 > date
2011-12-31
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
CNY
Earnings History > 38 > eps Actual
-0.0037
Earnings History > 38 > eps Estimate
0
Earnings History > 38 > eps Difference
-0.0037
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2011-09-30
Earnings History > 39 > report Date
2011-12-31
Earnings History > 39 > date
2011-09-30
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
CNY
Earnings History > 39 > eps Actual
0.0004
Earnings History > 39 > eps Estimate
0
Earnings History > 39 > eps Difference
0.0004
Earnings History > 39 > surprise Percent
-
Earnings History > 40 > period
2011-06-30
Earnings History > 40 > report Date
2011-09-30
Earnings History > 40 > date
2011-06-30
Earnings History > 40 > before After Market
-
Earnings History > 40 > currency
CNY
Earnings History > 40 > eps Actual
0.001
Earnings History > 40 > eps Estimate
0
Earnings History > 40 > eps Difference
0.001
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2011-03-31
Earnings History > 41 > report Date
2011-06-30
Earnings History > 41 > date
2011-03-31
Earnings History > 41 > before After Market
-
Earnings History > 41 > currency
CNY
Earnings History > 41 > eps Actual
0.0045
Earnings History > 41 > eps Estimate
0
Earnings History > 41 > eps Difference
0.0045
Earnings History > 41 > surprise Percent
-
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson's disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer. It also offers Shuluoke, Nuomoling, Weihong, and Xinweihong for various infections; Xuanning for hypertension; Encun to prevent atherosclerotic thrombosis events; Qixiao to treat upper respiratory tract infection; Linmeixin and Shuanglexin for diabetes; Gubang and Gubangjia to treat osteoporosis in postmenopausal women; and Gaoshunsong for arthritis, osteoarthritis, ankylosing spondylitis, frozen shoulder, bursuitis, tenosynovitis, acute gout, dysmenorrhea, toothache and postoperative pain, low back pain, sprain, strain, and other soft tissue injuries. In addition, the company provides Debixin for various ulcer; Qimaite for acute and chronic pains; antibiotics, vitamin C, and caffeine APIs; functional food products; and healthcare services. It has a strategic collaboration with AstraZeneca PLC to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the People's Republic of China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AI Expect Novo Nordisk To Outperform Eli Lilly In 2026: Here's Why Seeking Alpha
Read more →Eli Lilly, Novo waging price wars as obesity drug market heats up in China - Seeking Alpha
12/30/2025
Eli Lilly, Novo waging price wars as obesity drug market heats up in China Seeking Alpha
Read more →(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of CSPC Pharmaceutical Group Limited
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2021-06-30
EPS Actual
0.0165
EPS Estimate
0
EPS Difference
0.0165
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.